| Style | Citing Format |
|---|---|
| MLA | Nabavi SF, et al.. "Putative Therapeutic Impact of Inflammasome Inhibitors Against Covid-19-Induced Ards." Current Medicinal Chemistry, vol. 30, no. 12, 2023, pp. 1406-1419. |
| APA | Nabavi SF, Sahebnasagh A, Shahbazi A, Nabavi SM, Azimi S, Kashani MK, Habtemariam S, Rahmani M, Badiee M, Hashemi J, Saghafi F, Amini K, Azimi M, Rezabakhsh A (2023). Putative Therapeutic Impact of Inflammasome Inhibitors Against Covid-19-Induced Ards. Current Medicinal Chemistry, 30(12), 1406-1419. |
| Chicago | Nabavi SF, Sahebnasagh A, Shahbazi A, Nabavi SM, Azimi S, Kashani MK, Habtemariam S, et al.. "Putative Therapeutic Impact of Inflammasome Inhibitors Against Covid-19-Induced Ards." Current Medicinal Chemistry 30, no. 12 (2023): 1406-1419. |
| Harvard | Nabavi SF et al. (2023) 'Putative Therapeutic Impact of Inflammasome Inhibitors Against Covid-19-Induced Ards', Current Medicinal Chemistry, 30(12), pp. 1406-1419. |
| Vancouver | Nabavi SF, Sahebnasagh A, Shahbazi A, Nabavi SM, Azimi S, Kashani MK, et al.. Putative Therapeutic Impact of Inflammasome Inhibitors Against Covid-19-Induced Ards. Current Medicinal Chemistry. 2023;30(12):1406-1419. |
| BibTex | @article{ author = {Nabavi SF and Sahebnasagh A and Shahbazi A and Nabavi SM and Azimi S and Kashani MK and Habtemariam S and Rahmani M and Badiee M and Hashemi J and Saghafi F and Amini K and Azimi M and Rezabakhsh A}, title = {Putative Therapeutic Impact of Inflammasome Inhibitors Against Covid-19-Induced Ards}, journal = {Current Medicinal Chemistry}, volume = {30}, number = {12}, pages = {1406-1419}, year = {2023} } |
| RIS | TY - JOUR AU - Nabavi SF AU - Sahebnasagh A AU - Shahbazi A AU - Nabavi SM AU - Azimi S AU - Kashani MK AU - Habtemariam S AU - Rahmani M AU - Badiee M AU - Hashemi J AU - Saghafi F AU - Amini K AU - Azimi M AU - Rezabakhsh A TI - Putative Therapeutic Impact of Inflammasome Inhibitors Against Covid-19-Induced Ards JO - Current Medicinal Chemistry VL - 30 IS - 12 SP - 1406 EP - 1419 PY - 2023 ER - |